Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how fenretinide targets Ewing sarcoma through p38 MAPK-dependent cell death pathways, offering new hope for treating this aggressive childhood cancer.